HSV-1 clinical isolates with unique in vivo and in vitro phenotypes and insight into genomic differences Robert J. DanaherDerrick E. FoutsCraig S. Miller OriginalPaper 13 October 2016 Pages: 171 - 185
Phrenic nerve deficits and neurological immunopathology associated with acute West Nile virus infection in mice and hamsters Katherine ZukorHong WangJohn D. Morrey OriginalPaper Open access 19 October 2016 Pages: 186 - 204
Pseudo-typed Semliki Forest virus delivers EGFP into neurons Fan JiaHuan MiaoFuqiang Xu OriginalPaper 13 October 2016 Pages: 205 - 215
A decreasing CD4/CD8 ratio over time and lower CSF-penetrating antiretroviral regimens are associated with a higher risk of neurocognitive deterioration, independently of viral replication Matteo VassalloR. FabreC. Pradier OriginalPaper 04 November 2016 Pages: 216 - 225
JC polyomavirus expression and bell-shaped regulation of its SF2/ASF suppressor during the follow-up of multiple sclerosis patients treated with natalizumab Elena UleriGabriele IbbaAntonina Dolei OriginalPaper 03 November 2016 Pages: 226 - 238
Association of midlife smoking status with change in processing speed and mental flexibility among HIV-seropositive and HIV-seronegative older men: the Multicenter AIDS Cohort Study Wajiha Z. Akhtar-KhaleelRobert L. CookMichael Plankey OriginalPaper 26 November 2016 Pages: 239 - 249
Soluble TLR2 and 4 concentrations in cerebrospinal fluid in HIV/SIV-related neuropathological conditions Khutso M. MothapoJ. ten OeverA. J. van der Ven OriginalPaper 23 November 2016 Pages: 250 - 259
Greater decline in memory and global neurocognitive function in HIV/hepatitis C co-infected than in hepatitis C mono-infected patients treated with pegylated interferon and ribavirin Theodore R. MillerJeffrey J. WeissMonica Rivera-Mindt OriginalPaper 28 November 2016 Pages: 260 - 272
Cognitive function in early HIV infection Aanchal PrakashJue HouAnn B. Ragin OriginalPaper 28 November 2016 Pages: 273 - 282
Increased cell-free mitochondrial DNA is a marker of ongoing inflammation and better neurocognitive function in virologically suppressed HIV-infected individuals Josué Pérez-SantiagoMichelli F. De OliveiraSanjay R. Mehta OriginalPaper 05 December 2016 Pages: 283 - 289
The anticancer drug sunitinib promotes autophagyand protects from neurotoxicity in an HIV-1 Tat model of neurodegeneration Jerel A. FieldsJeff MetcalfEliezer Masliah OriginalPaper 19 January 2017 Pages: 290 - 303
Vocal emotion processing deficits in HIV-infected individuals A. González-BaezaJ. R. ArribasF. Carvajal OriginalPaper 09 December 2016 Pages: 304 - 312
Reaction of complement factors and proteasomes in experimental encephalitis Stefan LangeTomas BergströmIvar Lönnroth OriginalPaper Open access 02 December 2016 Pages: 313 - 318
Neuroimaging abnormalities in clade C HIV are independent of Tat genetic diversity Robert H. PaulSarah PhillipsJohn Joska OriginalPaper 02 December 2016 Pages: 319 - 328
Cerebrospinal fluid anti-Epstein-Barr virus specific oligoclonal IgM and IgG bands in patients with clinically isolated and Guillain-Barré syndrome Diana FerraroVeronica GalliPatrizia Sola Short Communication 22 November 2016 Pages: 329 - 334
Acyclovir resistance in herpes simplex virus type I encephalitis: a case report M. BergmannR. BeerE. Schmutzhard Case Report Open access 27 October 2016 Pages: 335 - 337